Get Quote

Prana Biotechnology Limited (ADR) (NASDAQ:PRAN)

CAPS Game Rating: 1 out of 5

The Company develops therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer's disease.

Recs

0
Member Avatar phatchips767 (< 20) Submitted: 28/03/2012 20:16:24 : Outperform Start Price: $1.72 PRAN Score: +16.11

australian pharma. company works with alzheimers cures. mf rated it 5 stars , pe was -12.

Report this Post Reply

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.